Free, evidence-based clinical decision tools. Multilingual, mobile-friendly, designed for radiologists.
Categorize liver observations in at-risk patients. Major and ancillary features for HCC risk stratification.
Score thyroid nodules based on ultrasound features. Determines FNA recommendations by size thresholds.
Risk stratify adnexal masses. Both ultrasound (v2022) and MRI (2021) scoring systems.
Categorize pulmonary nodules on LDCT screening. Solid, part-solid, and ground-glass nodules.
Management recommendations for incidental pulmonary nodules. Risk-stratified follow-up intervals.
Calculate absolute and relative washout to differentiate adenomas from metastases/carcinomas.
Grade fatty liver disease using CT attenuation and MRI fat fraction measurements.
Calculate lesion volumes using sphere or ellipsoid formulas. Track growth with volume doubling time.
Evaluate tumor response to treatment. Calculate sum of target lesions and determine CR/PR/SD/PD.